All data are based on the daily closing price as of November 11, 2026
g

Grape King Bio

1707.TW
2.40 USD
-0.01
-0.41%

Overview

Last close
2.40 usd
Market cap
354.79M usd
52 week high
4.63 usd
52 week low
2.40 usd
Target price
4.2 usd

Valuation

P/E
10.2341
Forward P/E
17.3611
Price/Sales
1.1518
Price/Book Value
1.1474
Enterprise Value
250.49M usd
EV/Revenue
0.8132
EV/EBITDA
2.986

Key financials

Revenue TTM
308.03M usd
Gross Profit TTM
226.30M usd
EBITDA TTM
75.94M usd
Earnings per Share
0.23 usd
Dividend
N/A usd
Total assets
471.87M usd
Net debt
-105.45M usd

About

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; and microbial fermentation for mushroom mycelium, probiotics, and enzymes. It also offers functional ingredients for intestinal care, immunity regulation, liver care, brain health, eye care, weight control, feminine health, sensual health care, and others. It serves pharmaceutical preparations, finished drugs, oral liquids, and beverages and health foods. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.
  • Symbol
    1707.TW
  • Exchange
    TW
  • Isin
    TW0001707008
  • Country
    Taiwan
  • Sector
    Consumer Defensive
  • Industry
    Packaged Foods
  • CEO
    Mr. Bing-Jyun Cuei
  • Headquarter
    Taoyuan City
  • Web site
    https://www.grapeking.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top